RxDoctor Payments DataLook up a doctor →

Albert Riddle, MD

Geriatric Medicine · Haworth, NJNPI 1699724880

Payments from drug & device makers

$524,204in general payments, 2019–2025

Across 769 payments — averaging $681.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$328K
  • Neurocrine Biosciences, Inc.$159K
  • Sun Pharmaceutical Industries Inc.$21K
  • Johnson & Johnson$6K
  • Qiagen, LLC$4K
  • CMP Pharma, Inc.$3K
  • plus $3K from 6 others

What the payments were for

  • Consulting fees$72,70714%
  • Speaking & faculty fees$348,00866%
  • Travel & lodging$84,05916%
  • Food & beverage$19,4154%
  • Education$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$524,204 in reported general payments places this provider in the 95th percentile of 165 geriatric medicine providers in New Jersey.

See all geriatric medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$25,335
Medicare patients
138
Services billed
309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban184$70,464
VraylarCariprazine Hcl55$40,436
AristadaAripiprazole Lauroxil16$38,830
XareltoRivaroxaban124$37,053
RexultiBrexpiprazole47$27,178
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$21,363
Combivent RespimatIpratropium/Albuterol Sulfate33$16,764
TrulicityDulaglutide13$13,714
Incruse ElliptaUmeclidinium Bromide34$12,636
FarxigaDapagliflozin Propanediol41$12,543
JanumetSitagliptin Phos/Metformin Hcl35$11,635
TradjentaLinagliptin27$7,402
JanuviaSitagliptin Phosphate22$6,625
JardianceEmpagliflozin21$6,415
Spiriva HandihalerTiotropium Bromide12$6,101

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$6,201$37,053124 claims
Otsuka America Pharmaceutical, Inc.Rexulti$60$27,17847 claims
Lilly USA, LLCTrulicity$25$13,71413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 165 geriatric medicine providers in New Jersey.

Other geriatric medicine in Haworth

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →